ArticleNeuroscience bulletin2026
FMRP Regulates NrCAM Expression via β-catenin and Modulates PSD95, Dendritic Spines and Autism-like Behaviors.
Article in Neuroscience bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fragile X mental retardation protein (FMRP) and β-catenin play essential roles in dendritic development and neurobehavior, whereas the neuronal cell adhesion molecule (NrCAM) is closely involved in synapse formation and remodeling. However, whether FMRP regulates NrCAM through β-catenin to influence hippocampal dendritic development and neurobehavior remains unclear. Here, transcriptomic analysis of Fmr1 knockout (KO) mice identified Ctnnb1 as a key differentially expressed gene associated with aberrant dendritic development. FMRP directly binds to β-catenin mRNA in HT22 cells. Fmr1 knockdown upregulated β-catenin, NrCAM, and PSD95 expression at both the mRNA and protein levels and promoted the nuclear accumulation of β-catenin. NrCAM was required for the FMRP deficiency-induced upregulation of PSD95, and simultaneous knockdown of Fmr1 and Nrcam reduced PSD95 expression. Furthermore, Fmr1 knockdown enhanced the interaction between NrCAM and PSD95. In vivo hippocampal Nrcam knockdown in Fmr1 KO mice decreased PSD95 expression, whereas Ctnnb1 knockdown rescued dendritic spine abnormalities and ameliorated autism-like behaviors. These findings demonstrate that FMRP regulates NrCAM through β-catenin to modulate PSD95 expression, thereby influencing hippocampal dendritic spine development and autism-like behaviors. This study provides new mechanistic insights into the neuropathology of hereditary mental retardation.
Indexed as
Identifiers
42814250What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.